体育外围app软件
AstraZeneca is responding to the COVID-19 (novel coronavirus) outbreak, consistent with our values to follow the science, put patients first and do the right thing.
AstraZeneca is responding to the COVID-19 (novel coronavirus) outbreak, consistent with our values to follow the science, put patients first and do the right thing.
160 employees (as of 2019)
>50% of our senior roles are filled by women
Headquarters of the Europe & Canada Commercial Regional
team and the Europe & International Oncology teams
Since 1976 in Switzerland
Since 1999 as AstraZeneca AG in the canton of Zug
Validated “Great place to work”
70’600 employees (as of 2019)
45% of our senior roles are filled by women
6.1bn USD invested in R&D (>25% of revenue)
3 R&D sites in Cambridge (UK), Gothenburg (Sweden) and
Gaithersburg (USA)
Headquarter in Cambridge, UK
1913 Astra AB founded in Sweden
At AstraZeneca, we put science at the heart of everything we do. Our global research activities are focused on the discovery and development of life-changing medicines for diseases with unmet medical needs that affect millions of people around the world.
We have transformed our medicines 文件夹 by focusing on three therapy areas – Oncology, Cardiovascular, Renal and Metabolism and Respiratory. In other disease areas, we have maximised the value of our 文件夹 through licensing, collaboration and externalisation.
Here in Switzerland 160 employees in local and regional functions work on the mission to turn ideas into life-changing medicines. Our 团队 is curious 关于 science and the advancement of knowledge. Together we find creative ways to approach new challenges.
In 2020, AstraZeneca Switzerland was again rated by employees as an excellent place to work and was awarded the external label "Great place to work". This award confirms that employees trust their managers, are proud of their work and enjoy working with their colleagues.
For AstraZeneca, sustainability means being part of a healthy society and planet. We are committed to this through a variety of initiatives and projects around the world and in Switzerland.
CH-2337; 03/2020